EUVIMEDОткрийте EUVIMED
Open access · CC BY 4.0

CRISPR ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer

Haiwei Mou, Onur Eskiocak, Kadir A Özler, Megan Gorman iD, Junjiayu Yue, Ying Jin, Zhikai Wang, Ya Gao, Tobias Janowitz, Hannah V Meyer, Tianxiong Yu, John E Wilkinson and 3 more

The Journal of Pathology · 2023

DOI: 10.1002/path.6054 ↗

At a glance

Journal article in The Journal of Pathology, 2023. Written by Haiwei Mou and 14 co-authors. Institution: Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms. Cited 7 times so far (Crossref); 56 references. The full text is freely available (open access, CC BY 4.0). Funded by: NCATS NIH HHS, NIH HHS, NCI NIH HHS.

РезюмеSubjectsБиблиографски данниCiteRelated studies

Abstract (original language)

CRISPR/Cas9‐driven cancer modeling studies are based on the disruption of tumor suppressor genes by small insertions or deletions (indels) that lead to frame‐shift mutations. In addition, CRISPR/Cas9 is widely used to define the significance of cancer oncogenes and genetic dependencies in loss‐of‐function studies. However, how CRISPR/Cas9 influences gain‐of‐function oncogenic mutations is elusive. Here, we demonstrate that single guide RNA targeting exon 3 of Ctnnb1 (encoding β‐catenin) results in exon skipping and generates gain‐of‐function isoforms in vivo . CRISPR/Cas9‐mediated exon skipping of Ctnnb1 induces liver tumor formation in synergy with YAP S127A in mice. We define two distinct exon skipping‐induced tumor subtypes with different histological and transcriptional features. Notably, ectopic expression of two exon‐skipped β‐catenin transcript isoforms together with YAP S127A phenocopies the two distinct subtypes of liver cancer. Moreover, we identify similar CTNNB1 exon‐skipping events in patients with hepatocellular carcinoma. Collectively, our findings advance our understanding of β‐catenin‐related tumorigenesis and reveal that CRISPR/Cas9 can be repurposed, in vivo , to study gain‐of‐function mutations of oncogenes in cancer. © 2023 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsAnimalsMicebeta CateninCarcinogenesisExons

Author keywords

CRISPR/Cas9exon skippinghepatoblastomahepatocellular carcinomaliver cancerβ-catenin

Substances

beta CateninCTNNB1 protein, mouse

Authors and institutions

  • Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, USA.
  • Program in Bioinformatics and Integrative Biology, University of Massachusetts Medical School, Worcester, MA, USA.
  • Department of Comparative Medicine, University of Washington, Seattle, WA, USA.
  • Bioinformatics Core, University of Massachusetts Medical School, Worcester, MA, USA.
  • Department of Molecular Biosciences, The Wenner-Gren Institute, Stockholm University, Stockholm, Sweden.

ORCID profiles: Megan Gorman, Deniz M Ozata

Funding

  • NCATS NIH HHS
  • NIH HHS
  • NCI NIH HHS
  • Mark Foundation For Cancer Research
  • National Center for Advancing Translational Sciences
  • National Institutes of Health
  • Vetenskapsrådet
  • National Cancer Institute

Cite

APA

Mou, H., Eskiocak, O., Özler, K. A., Gorman, M., Yue, J., Jin, Y., Wang, Z., Gao, Y., Janowitz, T., Meyer, H. V., Yu, T., Wilkinson, J. E., Kucukural, A., Ozata, D. M., & Beyaz, S. (2023). CRISPR ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. The Journal of Pathology. https://doi.org/10.1002/path.6054

Vancouver

Mou H, Eskiocak O, Özler KA, Gorman M, Yue J, Jin Y, et al. CRISPR ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer. The Journal of Pathology. 2023. doi:10.1002/path.6054

BibTeX
@article{Mou2023,
  author = {Mou, Haiwei and Eskiocak, Onur and Özler, Kadir A and Gorman, Megan and Yue, Junjiayu and Jin, Ying and Wang, Zhikai and Gao, Ya and Janowitz, Tobias and Meyer, Hannah V and Yu, Tianxiong and Wilkinson, John E and Kucukural, Alper and Ozata, Deniz M and Beyaz, Semir},
  title = {CRISPR ‐induced exon skipping of β‐catenin reveals tumorigenic mutants driving distinct subtypes of liver cancer},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6054}
}
Start for free →